Synthesis of novel quinoxaline derivatives and its cytotoxic activities

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 15, 2009, Pages 4119-4121

  Tanimori, Shinji ^a   Nishimura, Takeshi ^a   Kirihata, Mitsunori ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Cascade reaction; Cytotoxic activity; Dihydroquinoxalin 2 one; Domino reaction; One pot synthesis; Quinoxaline; Ullmann reaction

Indexed keywords

2 HALOANILINE DERIVATIVE; ANILINE DERIVATIVE; COPPER; DIHYDROQUINOXALIN 2 ONE DERIVATIVE; IODIDE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IC 50; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTITUTION REACTION;

AMINO ACIDS; ANILINE COMPOUNDS; CATALYSIS; CHEMISTRY, PHARMACEUTICAL; COPPER; DRUG DESIGN; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; MOLECULAR STRUCTURE; QUINOXALINES; SOLVENTS; TEMPERATURE;

EID: 67649993442     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.06.007     Document Type: Article

References (19)

1. D. M. Leit, M. Silvana, P. Tessier, D. Smil, A. Wahhab, R. Deziel, S. Manku, J. Mancuso, E. Therrien, M. Allan, Y. A. Chantigny, A. Ajamian, P. Beaulieu, Preparation of histone deacetylase inhibitors. PCT Int. Appl., 2006, 367pp. CODEN: PIXXD2 WO 2006102760 A1 20061005 CAN 145:397546 AN 2006:1031695 CAPLUS.
2. Su D.-S., Markowitz M.K., DiPardo R.M., Murphy K.L., Harrell C.M., O'Malley S.S., Ransom R.W., Chang R.S.L., Ha S., Hess F.J., Pettibone D.J., Mason G.S., Boyce S., Freidinger R.M., and Bock M.G. J. Am. Chem. Soc. 125 (2003) 7516
3. TenBrink R.E., Im W.B., Sethy V.H., Tang A.H., and Carter D.B. J. Med. Chem. 37 (1994) 758
4. Abou-Gharbia M., Freed M.E., McCaully R.J., Silver P.J., and Wendt R.L. J. Med. Chem. 27 (1984) 1743
5. Jiang Q., Jiang D., Jiang Y., Fu H., and Zhao Y. Synlett (2007) 1836
6. Chicharro R., Castro S., Reino J.L., and Aran V.J. Eur. J. Org. Chem. (2003) 2314
7. Alo B.I., Avent A.G., Hanson J.R., and Ode A.E. J. Chem. Soc., Perkin Trans. 1 (1988) 1997
8. Soderberg B.C.G., Wallace J.M., and Tamariz J. Org. Lett. 4 (2002) 1339
9. Lai J.T. Synthesis (1982) 71
10. Ma et al. recently reported the similar reaction using 2-halotrifluoroacetanilides with pyrrole-2-carboxylate esters in the presence of CuI and l-proline to produce pyrrole[1,2-a]quinoxalines. They reported that the yield of a reaction using free aniline derivative lowered. The use of free carboxylic acid has not been reported, see:. Yuan Q., Ma D. J. Org. Chem. 73 (2008) 5159
11. Aranyos A., Old D.W., Kiyomori A., Wolfe J.P., Sadighi J.P., and Buchwald S.L. J. Am. Chem. Soc. 121 (1999) 4369
12. +], 181, 120, 107.
13. Although chiral amino acids were employed in entries 2, 5, 6, 7, and 8 (Table 3), the optical purities of products were unknown at present.
14. 50 is defined as the concentration, which results in a 50% decrease in cell number as compared with that of the control cultures in the absence of an inhibitor and were calculated using the respective regression analysis.
15. For selected examples, see:. Urquiola C., Vieites M., Torre M.H., Cabrera M., Lavaggi M.L., Cerecetto H., Gonzalez M., de Cerain A.L., Monge A., Smircich P., Garat B., and Gambino D. Bioorg. Med. Chem. 17 (2009) 1623
16. Driller K.M., Libnow S., Hein M., Harms M., Wende K., Lalk M., Michalik D., Reinke H., and Langer P. Org. Biomol. Chem. 6 (2008) 4218
17. Yan L., Liu F.-W., Dai G.-F., and Liu H.-M. Bioorg. Med. Chem. Lett. 17 (2007) 609
18. Carta A., Sanna P., Loriga M., Setzu M.G., La Colla P., and Loddo R. Farmaco 5 (2002) 19
19. Lawrence D.S., Copper J.E., and Smith C.D. J. Med. Chem. 44 (2001) 594